Evidence map›Paper›PMID 42032775›Full record

ArticleActa neuropathologica communications2026

Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.

Arnault Tauziède-Espariat, David Castel, Yassine Ajlil, Jacques Grill, Raphaël Saffroy, Lauren Hasty, Alice Métais, Kevin Beccaria, Nathalie Boddaert, Volodia Dangouloff-Ros and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Arnault Tauziède-EspariatDepartment of Neuropathology, GHU Paris-Psychiatrie Et Neurosciences, Sainte-Anne Hospital. 1, Rue Cabanis, 75014, Paris, France. a.tauziede-espariat@ghu-paris.fr.
David CastelU981, Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Yassine AjlilU981, Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Jacques GrillU981, Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Raphaël SaffroyDepartment of Biochemistry and Oncogenetic, Paul Brousse Hospital, 94804, Villejuif, France.
Lauren HastyDepartment of Neuropathology, GHU Paris-Psychiatrie Et Neurosciences, Sainte-Anne Hospital. 1, Rue Cabanis, 75014, Paris, France.
Alice MétaisDepartment of Neuropathology, GHU Paris-Psychiatrie Et Neurosciences, Sainte-Anne Hospital. 1, Rue Cabanis, 75014, Paris, France.
Kevin BeccariaDepartment of Pediatric Neurosurgery, Necker Hospital, APHP, Université Paris Descartes, Sorbonne Paris Cite, 75015, Paris, France.
Nathalie BoddaertPediatric Radiology Department, Hôpital Necker Enfants Malades, AP-HP, University de Paris, Paris, France.
Volodia Dangouloff-RosPediatric Radiology Department, Hôpital Necker Enfants Malades, AP-HP, University de Paris, Paris, France.
Pascale VarletDepartment of Neuropathology, GHU Paris-Psychiatrie Et Neurosciences, Sainte-Anne Hospital. 1, Rue Cabanis, 75014, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diffuse midline gliomaEGFRSOX10

Identifiers

PMID42032775
PMCPMC13251029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.